Scholars Central

Research articlePublished 2016

Inhibition of Tumors in Mice Models by a Synthetic Ceramide-analog AD2725

Authors: Qin JD, Weiss L, Zeira M, Yekhtin Z, Slavin S, Gatt S, Dagan A

Biochemistry & Pharmacology: Open Access

Volume 5 · Issue 3 · Pages 1–5

Abstract

A synthetic analog of ceramide (AD2725) elevated ceramide levels in MDA-MB-435 breast cancer cells inducing apoptosis and resulted in cell death. In animal studies, using a model of xenograft breast cancer cells in nude mice, treatment with AD2725 resulted in a significant reduction of the tumor volume and weight, and significantly prolonged survival of the treated mice. The analog also significantly elevated INF gamma and IL-12 cytokine levels and reduced the level of IL-10 in the plasma. These data indicate that use of suitable synthetic analogs that most probably elevate the ceramide levels may have beneficial anti-cancer therapeutic effects.

More from this journal

The newest in Biochemistry & Pharmacology: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalBiochemistry & Pharmacology: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Qin JD”
  • BylineArticles whose byline prints “Weiss L”
  • BylineArticles whose byline prints “Zeira M”
  • BylineArticles whose byline prints “Yekhtin Z”
  • BylineArticles whose byline prints “Slavin S”
  • BylineArticles whose byline prints “Gatt S”
  • BylineArticles whose byline prints “Dagan A”